STOCK TITAN

Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in spinal disorder treatments, has announced its participation in the 15th Annual Craig-Hallum Alpha Select Conference. The event will take place on November 19, 2024, at the Sheraton NY Times Square Hotel in New York City. CEO Sean Browne and CFO Scott Neils will represent the company in one-on-one meetings during the conference.

Xtant Medical Holdings (NYSE American: XTNT), un'azienda globale di tecnologia medica specializzata nei trattamenti per i disturbi spinali, ha annunciato la sua partecipazione alla 15ª Conferenza Annuale Craig-Hallum Alpha Select. L'evento si svolgerà il 19 novembre 2024 presso il Sheraton NY Times Square Hotel a New York. Il CEO Sean Browne e il CFO Scott Neils rappresenteranno l'azienda in incontri individuali durante la conferenza.

Xtant Medical Holdings (NYSE American: XTNT), una empresa global de tecnología médica especializada en tratamientos para trastornos de la columna vertebral, ha anunciado su participación en la 15ª Conferencia Anual Craig-Hallum Alpha Select. El evento se llevará a cabo el 19 de noviembre de 2024 en el Sheraton NY Times Square Hotel en la ciudad de Nueva York. El CEO Sean Browne y el CFO Scott Neils representarán a la empresa en reuniones uno a uno durante la conferencia.

Xtant Medical Holdings (NYSE American: XTNT), 척추 장애 치료를 전문으로 하는 글로벌 의료 기술 회사가 제15회 Craig-Hallum Alpha Select 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2024년 11월 19일 뉴욕시의 Sheraton NY Times Square Hotel에서 열릴 예정입니다. CEO Sean Browne와 CFO Scott Neils가 컨퍼런스 기간 동안 회사의 대표로 개별 회의에 참석할 것입니다.

Xtant Medical Holdings (NYSE American: XTNT), une entreprise mondiale de technologie médicale spécialisée dans les traitements des troubles de la colonne vertébrale, a annoncé sa participation à la 15ème Conférence Annuelle Craig-Hallum Alpha Select. L'événement aura lieu le 19 novembre 2024 au Sheraton NY Times Square Hotel à New York. Le PDG Sean Browne et le CFO Scott Neils représenteront l'entreprise lors de réunions individuelles durant la conférence.

Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das auf Behandlungen von Wirbelsäulenstörungen spezialisiert ist, hat seine Teilnahme an der 15. jährlichen Craig-Hallum Alpha Select Konferenz bekannt gegeben. Die Veranstaltung findet am 19. November 2024 im Sheraton NY Times Square Hotel in New York City statt. CEO Sean Browne und CFO Scott Neils werden das Unternehmen während der Konferenz in persönlichen Gesprächen vertreten.

Positive
  • None.
Negative
  • None.

BELGRADE, MT / ACCESSWIRE / November 11, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced announced that Sean Browne, CEO and Scott Neils, CFO will be attending the following upcoming conference:

Event: 15th Annual Craig-Hallum Alpha Select Conference
Date: November 19, 2024
Location: Sheraton NY Times Square Hotel, New York, NY
Format: 1x1 Meetings

For more information, please visit: https://www.meetmax.com/sched/event_110237/conference_home.html?bank_access=0&event_id=110237

About Xtant Medical Holdings, Inc.

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.

The symbols ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "intends," "expects," "anticipates," "plans," "believes," "estimates," "continue," "future," "will," "potential," "going forward," similar expressions or the negative thereof, and the use of future dates. Forward-looking statements in this release include the Company's expectations regarding the private placement, the timing for closing and the anticipated gross proceeds and use of net proceeds from the private placement. The Company cautions that its forward-looking statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: risks and uncertainties surrounding the private placement; the Company's future operating results and financial performance; its ability to increase or maintain revenue; the Company's ability to become operationally self-sustaining and less reliant on third-party manufacturers and suppliers; risks associated with its acquisitions and the integration of those businesses; the Company's ability to implement successfully its future growth initiatives and risks associated therewith; possible future impairment charges to long-lived assets and goodwill and write-downs of excess inventory; the ability to remain competitive; the ability to innovate, develop and introduce new products and the success of those products; the ability to engage and retain new and existing independent distributors and agents and qualified personnel and the Company's dependence on key independent agents for a significant portion of its revenue; the effect of labor and hospital staffing shortages on the Company's business, operating results and financial condition, especially when they affect key markets; the effect of inflation, increased interest rates and other recessionary factors and supply chain disruptions; the effect of product sales mix changes on the Company's financial results; government and third-party coverage and reimbursement for Company products; the ability to obtain and maintain regulatory approvals and comply with government regulations; the effect of product liability claims and other litigation to which the Company may be subject; the effect of product recalls and defects; the ability to obtain and protect Company intellectual property and proprietary rights and operate without infringing the rights of others; risks associated with the Company's clinical trials; international risks; the ability to service Company debt, comply with its debt covenants and access additional indebtedness; the ability to obtain additional financing on favorable terms or at all; and other factors. Additional risk factors are contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on April 1, 2024 and subsequent SEC filings by the Company. Investors are encouraged to read the Company's filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by this cautionary statement.

Investor Relations Contact

Brett Maas
Managing Partner, Hayden IR
brett@haydenir.com
(646) 536-7331

SOURCE: Xtant Medical Holdings, Inc.



View the original press release on accesswire.com

FAQ

When is Xtant Medical (XTNT) attending the Craig-Hallum Alpha Select Conference in 2024?

Xtant Medical (XTNT) will attend the Craig-Hallum Alpha Select Conference on November 19, 2024, at the Sheraton NY Times Square Hotel in New York City.

Who will represent Xtant Medical (XTNT) at the 2024 Craig-Hallum Conference?

CEO Sean Browne and CFO Scott Neils will represent Xtant Medical (XTNT) at the conference.

What type of meetings will Xtant Medical (XTNT) conduct at the 2024 Craig-Hallum Conference?

Xtant Medical (XTNT) will conduct one-on-one meetings during the conference.

Where will the 15th Annual Craig-Hallum Conference featuring Xtant Medical (XTNT) be held?

The conference will be held at the Sheraton NY Times Square Hotel in New York City.

Xtant Medical Holdings, Inc.

NYSE:XTNT

XTNT Rankings

XTNT Latest News

XTNT Stock Data

73.31M
138.71M
7.83%
64.97%
0.16%
Medical Devices
Biological Products, (no Disgnostic Substances)
Link
United States of America
BELGRADE